Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations. uri icon

Overview

authors

  • Ortiz, Michael V.
  • Gerdemann, Ulrike
  • Raju, Sandya Govinda
  • Henry, Dahlia
  • Smith, Steve
  • Rothenberg, S Michael
  • Cox, Michael C
  • Proust, Stéphanie
  • Bender, Julia Glade
  • Frazier, A Lindsay
  • Anderson, Peter
  • Pappo, Alberto S

publication date

  • April 14, 2020

Identity

PubMed Central ID

  • PMC7450975

Scopus Document Identifier

  • 85086464537

Digital Object Identifier (DOI)

  • 10.1200/PO.19.00401

PubMed ID

  • 32923911

Additional Document Info

volume

  • 4